EU member-states have been urged to do more to safeguard the supply of medicines post-Brexit by European pharmaceutical leaders. The European Federation of Pharmaceutical Industries and Associations called on European leaders to allow medicines and medical devices quality which is tested in the United Kingdom, to be recognised in the European Union. [...]
About Richie DThis author has not yet filled in any details.
So far Richie D has created 12 blog entries.
Following the European Medicines Agency leaving its London premises on 1 March, the agency is now operating from Amsterdam. The staff will gradually move into the Spark building in Amsterdam Sloterdijk. The EMA has been working hard with the Dutch authorities to ensure these temporary premises would be ready to move into [...]
When medicinal products are imported into the EU, they must undergo batch testing within the European Economic Area (EEA). Once the United Kingdom leave the EU due to Brexit, it has the following effects on the Pharmaceutical industry. Pharmaceutical manufacturers who have previously carried out batch testing in the UK must relocate [...]
The European Medicines Agency (EMA) has updated the agency’s Brexit-related guidance documents. The updated documents support pharmaceutical companies in preparing for the United Kingdom’s (UK) withdrawal from the European Union (EU). All medicinal products that are manufactured or imported into the European Economic Area (EEA) must be follow EU Good Manufacturing Practices [...]
IQVIA, the US firm that provides support services in the pharmaceutical, biotech and medical sectors have announced 100 new jobs in Dublin. They have begun recruiting in areas of clinical project management, data management and biostatistics. IQVIA stated how they are seeking pharmacovigilance specialists also. The company expect the jobs to be [...]
In relation to the decision on whether a deal will be made or not on Brexit, the outcome will have a big threat on pharmaceutical research and manufacturing in the United Kingdom, the industry has said. This will potentially be driving up manufacturing costs and minimising future investment. A range of companies [...]
The EU Mutual Recognition Agreement (MRA) with the USA was increased by two further countries. The companies that have been included are Poland and Slovenia. At present, there is a total of 22 countries recognised. Germany is still missing from this Mutual Recognition. A deadline has been established for all authorities and [...]
The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) have released further guidance on how a no-Brexit deal will effect clinical trials, namely: The regulation of medicines The regulation of medical devices The regulation of clinical trials The scenario of a so called “Hard Brexit” is still a possibility and people need [...]
There is still a very strong possibility that there will be a “Hard Brexit”. The term “Hard Brexit” refers to the United Kingdom leaving the European Union without a deal. The UK Government is now preparing legislation to allow the continued sale of and access to medicines manufactured in the remaining EU. [...]
The European Medicines Agency has begun the process of relocating to their new headquarters located in Amsterdam. The EMA will leave its premises in London on the 1st March 2019. They will temporarily move over to the 'Spark Building' (Orlyplein 24, 1043 DP Amsterdam, The Netherlands). This temporary location will hold visits [...]